Clovis Oncology, Inc. ( CLVS ) was a big mover last session as the company saw its shares surge 16% on the day. This rally higher can be attributable to solid volume too with far more shares changing hands than in a normal session. This broke the recent trend of the company, as the stock is now trading above the volatile price range of $47.83 to $54.91 in the past one-month time frame.
The company has seen 2 downward revisions in the past month, while its Zacks Consensus Estimate of a loss widened over the same timeframe, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent move higher can last.
Clovis Oncology currently carries a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Other attractive players in the healthcare industry include Gilead Sciences Inc. ( GILD ), Myriad Genetics Inc. ( MYGN ) and ANI Pharmaceuticals, Inc. ( ANIP ), all carrying a Zacks Rank #1 (Strong Buy).
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.